Investigation of change in residence-time in repeated radioimmunotherapy using I-131 rituximab for non-hodgkin's lymphoma

被引：0
|
作者：
Lim, S. [1 ]
Park, J. [1 ]
Kim, K. [1 ]
Kang, H. [1 ]
Choi, T. [1 ]
Kim, J. [1 ]
Woo, S. [1 ]
Kim, J. [1 ]
Kim, B. [1 ]
Cheon, G. [1 ]
机构：
[1] Korea Inst Radiol & Med Sci, Dept Med, Lab Nucl Med Res, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [21] Clinical scale preparation and evaluation of 131I-Rituximab for Non-Hodgkin's Lymphoma
    Kameswaran, Mythili
    Vimalnath, K. Viswanathan
    Rajeswari, Ardhi
    Joshi, Prahlad Vasudeo
    Sarma, H. D.
    Samuel, Grace
    RADIOCHIMICA ACTA, 2014, 102 (06) : 553 - 560
  • [22] Radioimmunotherapy in the Tratment of Non-Hodgkin's Lymphoma
    Whelton, Stacey
    NURSE PRACTITIONER, 2007, 32 (12): : 35 - 38
  • [23] Radioimmunotherapy of non-Hodgkin's lymphoma revisited
    Goldenberg, DM
    Sharkey, RM
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (02) : 383 - 384
  • [24] Dosimetry and radioimmunotherapy of non-Hodgkin's lymphoma
    Postema, EJ
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (12) : 2126 - 2127
  • [25] Radioimmunotherapy (RIT) of non-Hodgkin's lymphoma (NHL) with I-131 anti-CD20 monoclonal antibody (Bexxar™).: Preliminary results
    Antonescu, C
    Buchegger, F
    Kosinski, M
    Ketterer, N
    Kovacsovics, T
    Helg, C
    Delaloye, AB
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 980 - 980
  • [26] Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab
    Kaminski, MS
    Radford, JA
    Gregory, SA
    Leonard, JP
    Knox, SJ
    Kroll, S
    Wahl, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7985 - 7993
  • [27] Prior rituximab exposure does not affect response to radioimmunotherapy for non-Hodgkin's lymphoma
    Udall, D.
    Wahl, R.
    Jacene, H.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [28] Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin’s lymphoma
    Peter L. Roberson
    Hanan Amro
    Scott J. Wilderman
    Anca M. Avram
    Mark S. Kaminski
    Matthew J. Schipper
    Yuni K. Dewaraja
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 874 - 883
  • [29] Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma
    Roberson, Peter L.
    Amro, Hanan
    Wilderman, Scott J.
    Avram, Anca M.
    Kaminski, Mark S.
    Schipper, Matthew J.
    Dewaraja, Yuni K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (05) : 874 - 883
  • [30] Biodistribution and individual dosimetry of I-131-labeled Rituximab in relapsed non-Hodgkin's lymphoma
    Scheidhauer, K
    Wolf, I
    von Schilling, C
    Schmidt, B
    Baumgartl, H
    Reidel, G
    Peschel, C
    Schwaiger, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 981 - 981
12345